A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer

NCT07389733 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Unresectable or Metastatic Breast Cancer of Adults

Interventions

DRUG: HRS-6208 Capsule
DRUG: HRS-6209 Capsule
DRUG: HRS-8080 Tablet
DRUG: Fulvestrant injection
DRUG: Letrozole tablets

Sponsor

Shandong Suncadia Medicine Co., Ltd.